Population
167 patients with coronary artery disease (CAD)
Design
Cross-sectional
Authors
Loading...
Supports TNF-α/receptors as markers of cardiorenal impairment in CAD; leaves open genetic influence of AMPD1/ADA variants.
Plasma concentrations of TNF-alpha and its soluble receptors reflect cardiac and renal impairment in CAD patients, but are not influenced by AMPD1 or ADA genetic polymorphisms.
Safranow et al. (2009) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: